Under this call 12 EU-OPENSCREEN-DRIVE partner institutions will each offer one predefined screening technology to external users. The user will provide the biological question and the related assay matching the offered techniques. The offered…
Keys to Japan is an European Commission-funded initiative, managed by the EU-Japan Centre. If you are considering marketing a product or service in Japan and you are an SME from an EU Member-State or COSME Third Country, under Keys to Japan, you can…
The Emerging Technologies Competition is the Royal Society of Chemistry’s annual initiative for early stage companies and academic entrepreneurs who want to commercialise their technologies to make a global impact.
The “Future Award Healthcare Industry” is awarded annually by the Club of Healthcare Industry (cdgw). The award consists of two parts: a reward of 5,000 euros and a publication of the award winner in the professional magazine “kma” (Thieme group).…
The 2020 EU Gateway | Business Avenues Healthcare & Medical Technologies business mission to Korea is confirmed from 16-20 March.
Up to 50 European companies will be selected and receive coaching during the application stage, the week-long mission…
The G4A Growth and Advance Tracks offer a gateway to partner with Bayer in the digital health space. The business challenges include the field of cardiovascular, dermatology, digital therapeutics, global health, neurotech, oncology, ophthalmology,…
Advanced Material Competition
23 September - 8 October 2019
Call for start-ups is now open!
AdMaCom addresses scientific driven startups with outstanding technologies and business models in the area of Advanced Materials. This year, AdMaCom will…
LEDGER, a European project financed by the European Commission, is looking for 32 human centric innovators to develop Minimum Viable Products and Services, in order to achieve new models that preserve citizens’ digital sovereignty, where data is a…
A Berlin university holding a patent application for a microstructured polymer stent is looking for a licensing or research partner in order to develop the stent further from prototype to large scale application. The stent can be used to…
